BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 21495116)

  • 1. Cognitive status correlates with white matter alteration in Parkinson's disease.
    Hattori T; Orimo S; Aoki S; Ito K; Abe O; Amano A; Sato R; Sakai K; Mizusawa H
    Hum Brain Mapp; 2012 Mar; 33(3):727-39. PubMed ID: 21495116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between cognitive impairment and white-matter alteration in Parkinson's disease with dementia: tract-based spatial statistics and tract-specific analysis.
    Kamagata K; Motoi Y; Tomiyama H; Abe O; Ito K; Shimoji K; Suzuki M; Hori M; Nakanishi A; Sano T; Kuwatsuru R; Sasai K; Aoki S; Hattori N
    Eur Radiol; 2013 Jul; 23(7):1946-55. PubMed ID: 23404139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gray and white matter imaging: A biomarker for cognitive impairment in early Parkinson's disease?
    Duncan GW; Firbank MJ; Yarnall AJ; Khoo TK; Brooks DJ; Barker RA; Burn DJ; O'Brien JT
    Mov Disord; 2016 Jan; 31(1):103-10. PubMed ID: 26202802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative analysis of cognitive profiles and white-matter alterations using voxel-based diffusion tensor imaging between patients with Parkinson's disease dementia and dementia with Lewy bodies.
    Lee JE; Park HJ; Park B; Song SK; Sohn YH; Lee JD; Lee PH
    J Neurol Neurosurg Psychiatry; 2010 Mar; 81(3):320-6. PubMed ID: 19828477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered functional connectivity in the default mode network is associated with cognitive impairment and brain anatomical changes in Parkinson's disease.
    Lucas-Jiménez O; Ojeda N; Peña J; Díez-Cirarda M; Cabrera-Zubizarreta A; Gómez-Esteban JC; Gómez-Beldarrain MÁ; Ibarretxe-Bilbao N
    Parkinsonism Relat Disord; 2016 Dec; 33():58-64. PubMed ID: 27659747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of White Matter Lesions in Parkinson's Disease: Voxel-based Analysis and Tract-based Spatial Statistics Analysis of Parkinson's Disease with Mild Cognitive Impairment.
    Pu W; Shen X; Huang M; Li Z; Zeng X; Wang R; Shen G; Yu H
    Curr Neurovasc Res; 2020; 17(4):480-486. PubMed ID: 32875986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffusion tensor imaging reveals white matter changes associated with cognitive status in patients with Parkinson's disease.
    Deng B; Zhang Y; Wang L; Peng K; Han L; Nie K; Yang H; Zhang L; Wang J
    Am J Alzheimers Dis Other Demen; 2013 Mar; 28(2):154-64. PubMed ID: 23271331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. White matter abnormalities in Parkinson's disease patients with glucocerebrosidase gene mutations.
    Agosta F; Kostic VS; Davidovic K; Kresojević N; Sarro L; Svetel M; Stanković I; Comi G; Klein C; Filippi M
    Mov Disord; 2013 Jun; 28(6):772-8. PubMed ID: 23418083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Grey matter atrophy in cognitively impaired Parkinson's disease.
    Melzer TR; Watts R; MacAskill MR; Pitcher TL; Livingston L; Keenan RJ; Dalrymple-Alford JC; Anderson TJ
    J Neurol Neurosurg Psychiatry; 2012 Feb; 83(2):188-94. PubMed ID: 21890574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of white matter characteristics with tract-based spatial statistics according to diffusion tensor imaging in early Parkinson's disease.
    Li XR; Ren YD; Cao B; Huang XL
    Neurosci Lett; 2018 May; 675():127-132. PubMed ID: 29199095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of gray and white matter density in patients with Parkinson's disease dementia and dementia with Lewy bodies using voxel-based morphometry.
    Lee JE; Park B; Song SK; Sohn YH; Park HJ; Lee PH
    Mov Disord; 2010 Jan; 25(1):28-34. PubMed ID: 19908327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain volumetry in Parkinson's disease with and without dementia: where are the differences?
    Lee SH; Kim SS; Tae WS; Lee SY; Lee KU; Jhoo J
    Acta Radiol; 2013 Jun; 54(5):581-6. PubMed ID: 23474765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal study of cognitive and cerebral metabolic changes in Parkinson's disease.
    Baba T; Hosokai Y; Nishio Y; Kikuchi A; Hirayama K; Suzuki K; Hasegawa T; Aoki M; Takeda A; Mori E
    J Neurol Sci; 2017 Jan; 372():288-293. PubMed ID: 28017230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural and functional imaging study in dementia with Lewy bodies and Parkinson's disease dementia.
    Borroni B; Premi E; Formenti A; Turrone R; Alberici A; Cottini E; Rizzetti C; Gasparotti R; Padovani A
    Parkinsonism Relat Disord; 2015 Sep; 21(9):1049-55. PubMed ID: 26109553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal lobe atrophy on MRI in Parkinson disease with dementia: a comparison with Alzheimer disease and dementia with Lewy bodies.
    Tam CW; Burton EJ; McKeith IG; Burn DJ; O'Brien JT
    Neurology; 2005 Mar; 64(5):861-5. PubMed ID: 15753423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes of brain structure in Parkinson's disease patients with mild cognitive impairment analyzed via VBM technology.
    Gao Y; Nie K; Huang B; Mei M; Guo M; Xie S; Huang Z; Wang L; Zhao J; Zhang Y; Wang L
    Neurosci Lett; 2017 Sep; 658():121-132. PubMed ID: 28823894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. White matter damage in patients with mild cognitive impairment in Parkinson's disease.
    Li QQ; Wu K; Xu JL; Yin L
    Quant Imaging Med Surg; 2022 Feb; 12(2):1290-1298. PubMed ID: 35111624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mild cognitive impairment in Parkinson's disease is associated with a distributed pattern of brain white matter damage.
    Agosta F; Canu E; Stefanova E; Sarro L; Tomić A; Špica V; Comi G; Kostić VS; Filippi M
    Hum Brain Mapp; 2014 May; 35(5):1921-9. PubMed ID: 23843285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. White matter hyperintensities do not impact cognitive function in patients with newly diagnosed Parkinson's disease.
    Dalaker TO; Larsen JP; Dwyer MG; Aarsland D; Beyer MK; Alves G; Bronnick K; Tysnes OB; Zivadinov R
    Neuroimage; 2009 Oct; 47(4):2083-9. PubMed ID: 19539037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlations between gray matter reductions and cognitive deficits in dementia with Lewy Bodies and Parkinson's disease with dementia.
    Sanchez-Castaneda C; Rene R; Ramirez-Ruiz B; Campdelacreu J; Gascon J; Falcon C; Calopa M; Jauma S; Juncadella M; Junque C
    Mov Disord; 2009 Sep; 24(12):1740-6. PubMed ID: 19569130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.